Researchers at UVA developed an AI imaging tool using PET/MR to distinguish treatment effects from tumor progression in glioblastoma patients.
Key Details
- 1AI tool analyzes PET/MR imaging findings in glioblastoma cases.
- 2Distinguishes between tissue changes due to treatment vs. tumor progression.
- 3Current monitoring approaches often require a waiting period of 3+ months.
- 4Faster distinction could enable earlier treatment modification for recurrence.
- 5Method developed by a University of Virginia team.
Why It Matters
Improved differentiation between treatment effects and recurrence could allow clinicians to adjust therapies more quickly, potentially improving outcomes for a highly aggressive brain cancer. This underlines the growing significance of AI-assisted multi-modal imaging in oncology workflows.
Source
Health Imaging
Related News
•Health Imaging
AI as Second Reader Surpasses Radiologists in Breast Cancer Screening
AI used as a second reader on mammograms improves cancer detection rates compared to radiologists alone.
•Health Imaging
AI-Powered Ultrasound Tool Predicts Delivery Timing for Pregnant Patients
Researchers have created an AI model using ultrasound to accurately forecast expectant mothers’ delivery timelines.
•AuntMinnie
ChatGPT-4 Turbo Powers Postdeployment Monitoring of ICH Detection AI
Researchers found ChatGPT-4 Turbo could efficiently monitor the performance of Aidoc's ICH detection AI across real-world radiology practices.